Literature DB >> 16584934

Renal insufficiency-induced bone loss is associated with an increase in bone size and preservation of strength in rat proximal femur.

Jarkko Jokihaara1, Teppo L N Järvinen, Pasi Jolma, Peeter Kööbi, Jarkko Kalliovalkama, Juha Tuukkanen, Heikki Saha, Harri Sievänen, Pekka Kannus, Ilkka Pörsti.   

Abstract

Chronic renal insufficiency (CRI) results in phosphate retention and secondary hyperparathyroidism, the treatment of which is largely based on the use of calcium salts as phosphate binders. Advanced CRI causes bone fragility, but information about bone geometry and strength in moderate CRI is scarce. We assigned 39 8-week-old male Sprague-Dawley rats to sham-operation (Sham) or 5/6 nephrectomy (NTX). Four weeks later, the rats were randomized to 0.3% calcium (Sham, NTX) or 3.0% calcium diet (Sham + Calcium, NTX + Calcium). After 8 weeks, the animals were sacrificed, plasma samples collected, and femora excised for neck and midshaft analyses: dual-energy X-ray absorptiometry, peripheral quantitative computed tomography, and biomechanical testing. The NTX increased plasma urea and PTH 1.6-fold and 3.6-fold, respectively, whereas high calcium intake suppressed PTH to 30% of controls. Total femoral bone mineral content decreased (-6.3%) in the NTX group, while this deleterious effect was reversed by high calcium diet. In the site-specific analysis of the femoral neck, the volumetric bone density (-6.5%) was decreased in the NTX group but not NTX + Calcium group. However, in the nephrectomized rats, there was also a concomitant increase in the cross-sectional area (+15%), and, despite the decrease in bone density, the mechanical strength of the femoral neck was maintained. In the midshaft, NTX decreased cortical volumetric bone density (-1.2%), but similar to the femoral neck, no differences were found in the mechanical strength. In conclusion, a decrease in bone mass in moderate experimental CRI was associated with a concomitant increase in bone size, and maintenance of mechanical competence. Although high calcium diet suppressed plasma PTH to under normal physiological levels, it prevented the CRI-induced loss of bone mass without an adverse influence on bone strength.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584934     DOI: 10.1016/j.bone.2006.01.157

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  10 in total

1.  Quantitative (31)P NMR spectroscopy and (1)H MRI measurements of bone mineral and matrix density differentiate metabolic bone diseases in rat models.

Authors:  Haihui Cao; Ara Nazarian; Jerome L Ackerman; Brian D Snyder; Andrew E Rosenberg; Rosalynn M Nazarian; Mirko I Hrovat; Guangping Dai; Dionyssios Mintzopoulos; Yaotang Wu
Journal:  Bone       Date:  2010-02-24       Impact factor: 4.398

2.  Compressive axial mechanical properties of rat bone as functions of bone volume fraction, apparent density and micro-ct based mineral density.

Authors:  Esther Cory; Ara Nazarian; Vahid Entezari; Vartan Vartanians; Ralph Müller; Brian D Snyder
Journal:  J Biomech       Date:  2009-12-08       Impact factor: 2.712

3.  Shortcomings of DXA to assess changes in bone tissue density and microstructure induced by metabolic bone diseases in rat models.

Authors:  A Nazarian; E Cory; R Müller; B D Snyder
Journal:  Osteoporos Int       Date:  2008-05-31       Impact factor: 4.507

4.  Bone mass and strength in older men with type 2 diabetes: the Osteoporotic Fractures in Men Study.

Authors:  Moira A Petit; Misti L Paudel; Brent C Taylor; Julie M Hughes; Elsa S Strotmeyer; Ann V Schwartz; Jane A Cauley; Joseph M Zmuda; Andrew R Hoffman; Kristine E Ensrud
Journal:  J Bone Miner Res       Date:  2010-02       Impact factor: 6.741

5.  The effect of naturally occurring chronic kidney disease on the micro-structural and mechanical properties of bone.

Authors:  Anna Shipov; Gilad Segev; Hagar Meltzer; Moran Milrad; Ori Brenner; Ayelet Atkins; Ron Shahar
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

6.  The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease.

Authors:  Dariusz Pawlak; Ewa Oksztulska-Kolanek; Beata Znorko; Tomasz Domaniewski; Joanna Rogalska; Alicja Roszczenko; Małgorzata Michalina Brzóska; Anna Pryczynicz; Andrzej Kemona; Krystyna Pawlak
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

7.  Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Tomasz Domaniewski; Ewa Oksztulska-Kolanek; Beata Znorko; Alicja Roszczenko; Joanna Rogalska; Malgorzata M Brzoska; Pawel Lipowicz; Michal Doroszko; Anna Pryczynicz; Dariusz Pawlak
Journal:  Front Physiol       Date:  2017-10-31       Impact factor: 4.566

8.  Phosphate Binding with Sevelamer Preserves Mechanical Competence of Bone Despite Acidosis in Advanced Experimental Renal Insufficiency.

Authors:  Jarkko Jokihaara; Ilkka H Pörsti; Harri Sievänen; Peeter Kööbi; Pekka Kannus; Onni Niemelä; Russell T Turner; Urszula T Iwaniec; Teppo L N Järvinen
Journal:  PLoS One       Date:  2016-09-22       Impact factor: 3.240

9.  The Influence of Chronic Kidney Disease on the Structural and Mechanical Properties of Canine Bone.

Authors:  A Shipov; R Shahar; N Sugar; G Segev
Journal:  J Vet Intern Med       Date:  2017-11-30       Impact factor: 3.333

10.  A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease.

Authors:  Bartlomiej Kalaska; Krystyna Pawlak; Ewa Oksztulska-Kolanek; Tomasz Domaniewski; Beata Znorko; Malgorzata Karbowska; Aleksandra Citkowska; Joanna Rogalska; Alicja Roszczenko; Malgorzata M Brzoska; Dariusz Pawlak
Journal:  PeerJ       Date:  2017-04-20       Impact factor: 2.984

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.